1. Adil, A., & Godwin, M. (2017). The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis. Journal of the American Academy of Dermatology, 77(1), 136–141.e5.
2. Chin E. Y. (2013). Androgenetic alopecia (male pattern hair loss) in the United States: what treatments should primary care providers recommend?. Journal of the American Association of Nurse Practitioners, 25(8), 395–401.
3. Hillmer, A. M., Hanneken, S., Ritzmann, S., Becker, T., Freudenberg, J., Brockschmidt, F. F., Flaquer, A., Freudenberg-Hua, Y., Jamra, R. A., Metzen, C., Heyn, U., Schweiger, N., Betz, R. C., Blaumeiser, B., Hampe, J., Schreiber, S., Schulze, T. G., Hennies, H. C., Schumacher, J., Propping, P., … Nothen, M. M. (2005). Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. American journal of human genetics, 77(1), 140–148.
4. Kaiser, M., Abdin, R., Gaumond, S. I., Issa, N. T., & Jimenez, J. J. (2023). Treatment of Androgenetic Alopecia: Current Guidance and Unmet Needs. Clinical, cosmetic and investigational dermatology, 16, 1387–1406.
5. Randolph, M., & Tosti, A. (2021). Oral minoxidil treatment for hair loss: A review of efficacy and safety. Journal of the American Academy of Dermatology, 84(3), 737–746.
6. Rhodes, T., Girman, C. J., Savin, R. C., Kaufman, K. D., Guo, S., Lilly, F. R., Siervogel, R. M., & Chumlea, W. C. (1998). Prevalence of male pattern hair loss in 18-49 year old men. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 24(12), 1330–1332.